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ABSTRACT.
Purpose: We aimed to investigate changes in retinal vascular geometry over time after
panretinal photocoagulation (PRP) in patients with proliferative diabetic retinopathy (PDR).
Methods: Thirty-seven eyes with PDR were included. Wide-ﬁeld ﬂuorescein angiography
(Optomap, Optos PLC., Dunfermline, Scotland, UK) was used to diagnose PDR at baseline
and to assess activity at follow-up month three and six. At each time-point, a trained grader
measured retinal vessel geometry on optic disc (OD) centred images using semiautomated
software (SIVA, Singapore I Vessel Assessment, National University of Singapore,
Singapore) according to a standardized protocol.
Results: At baseline, the mean age and duration of diabetes were 52.8 and 22.3 years,
and 65% were male. Mean HbA1c was 69.9 mmol/mol, and blood pressure was 155/
84 mmHg. Of the 37 eyes with PDR, eight (22%) eyes had progression at month three and
13 (35%) progressed over six months. Baseline characteristics, including age, sex, duration
of diabetes, HbA1c, blood pressure, vessel geometric variables and total amount of laser
energy delivered did not diﬀer by progression status. However, compared to patients with
progression of PDR, patients with favourable treatment outcome had alterations in the
retinal arteriolar structures from baseline to month six (calibre, 154.3 lm versus 159.5 lm,
p = 0.04, tortuosity 1.12 versus 1.10, p = 0.04) and in venular structures from baseline to
month three (fractal dimension 1.490 versus 1.499, p = 0.04, branching coeﬃcient (BC)
1.32 versus 1.37, p = 0.01).
Conclusion: In patients with PDR, successful PRP leads to alterations in the retinal vascular
structure.However, baseline retinal vascular geometry characteristics did not predict treatment
outcome.
Key words: clinical – computer-assisted – humans – NAVILAS – panretinal photocoagulation–
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Introduction
In 2015, 415 million people had dia-
betes on a global scale, and the number
is expected to rise to 642 million by
2040 (Rahelic 2016). Diabetic retinopa-
thy (DR) is the leading complication to
diabetes and is almost universal after
25 years (Grauslund et al. 2009; Che-
ung et al. 2010b; Wong et al. 2016). A
late stage complication to DR is PDR
which aﬀects approximately 7% of all
patients (Yau et al. 2012; Zheng et al.
2012). In PDR retinal hypoxia, an
upregulation of vascular endothelial
growth factor (VEGF) and subsequent
retinal neovascularization can lead to
vitreous haemorrhage, tractional reti-
nal detachment and severe visual loss
(Grauslund et al. 2009).
In 1976, the landmark Diabetic
Retinopathy Study (DRS) showed that
the risk of severe visual loss in PDR
could be reduced by 57% when treated
with PRP (DRS 1976). However, the
beneﬁcial mechanisms of PRP in pre-
venting PDR progression have never
been clearly understood (Cheung et al.
2010b; Wong et al. 2016).One theory is
that the laser energy delivered to the
retinal pigment epithelium is conducted
to the neurosensory retina, leading to
destruction of the aﬀected retinal areas,
thus reducing the hypoxic load (DRS
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1976, 1981; ETDRS 1991; Stefansson
et al. 1992). However, while PRP has
been the gold-standard of care in PDR,
interindividual variation exists and
some eyes with PDR continue to pro-
gress while others remain stable after
PRP. This has led to either insuﬃcient
or excessive treatment of some patients,
which could either increase the risk of
progression of PDR with severe visual
loss or laser-induced side-eﬀects like
visual ﬁeld loss, night-blindness and
macular oedema (DRS 1981; Ferris
et al. 1987; ETDRS 1991).
Studying the retinal vascular geom-
etry may provide clues to structural
changes after PRP (Cheung et al.
2015). Murray proposed in 1926, the
optimal arteriolar branching angle
(BA) to be 75 degrees (Murray 1926),
and any deviation from this was seen as
less optimal for the retinal circulatory
system. In recent years, it has become
possible to access local and global
retinal vessel geometric variables such
as calibre, fractal dimension (FD) and
tortuosity using new semiautomated
software which has enabled more accu-
rate and faster measurements (Cheung
et al. 2010a; Sasongko et al. 2010,
2011).
The aim of our study was to indi-
vidually predict the outcome of PRP
treatment in eyes with PDR. We
hypothesize that retinal vessel geomet-
ric variables may allow us to predict
progression of PDR after PRP. In a
cohort of patients with treatment-na€ıve
PDR, we aimed to investigate if retinal
vessel geometry at baseline could be
used to identify patients at risk of
progression of PDR after PRP treat-
ment. We also investigated if retinal
vessel geometry could be used as a
postoperative biomarker for PDR
activity at three (3 M) and six month
(6 M) follow-up.
Materials and Methods
We conducted a prospective clinical
interventional study of 38 eyes with
treatment-na€ıve PDR who were fol-
lowed for 6 months at Odense Univer-
sity Hospital, Odense, Denmark
between 1 August 2014 and 31 October
2015. The study was registered at
Clinical Trials (ID NCT02157350),
approved by the Regional Scientiﬁc
Ethics Committee (ID S-20140046),
The Danish Data Protection Agency
(ID 14/16546) and performed in
accordance with the criteria of the
Helsinki II Declaration and good clin-
ical practice. All patients gave
informed consent before inclusion in
the study. The inclusion criteria were
age above 18, no clinical signiﬁcant
macular oedema or treatment-demand-
ing cataract on the study eye.
At baseline, all patients provided a
full medical history and underwent
thorough slit lamp examination in
mydriasis (Tropicamid 10 mg/ml
(Mydriacyl) and phenylephrine 10%
(Metaoxedrin)). Optical coherence
tomography (OCT) and fundus pho-
tography with 45° OD centred image
were captured by a 3D OCT-2000
Spectral domain OCT (Topcon,
Tokyo, Japan), and wide-ﬁeld fundus
images and ﬂuorescein angiography
(Optomap; Optos PLC., Dunfermline,
Scotland, UK) were performed. The
baseline examinations were comple-
mented by measurement of blood pres-
sure (Omron 705CP, Hoofddrop, The
Netherlands) and haemoglobin A1c
(HbA1c). All examinations were per-
formed by trained personnel.
After baseline examinations, all
patients received PRP in two sessions
1 week apart by a navigated laser-
system (NAVILAS, OD-OS GmbH,
Berlin, Germany). Local anaesthetic
(Oxybuprocain Hydrochloride 0.4%)
was given prior to PRP, and a NAVI-
LAS 34 or 38 mm contact lens was
used during the treatment session. All
treatments were given by certiﬁed per-
sonnel (TLT and JG). All baseline
examinations were repeated at 3 M
and 6 M follow-up. Progression of
PDR was deﬁned as new vessel forma-
tion, expanding area of minimum one
proliferation or increased area of ﬂuo-
rescein leakage on angiography, as
deﬁned by clinical guidelines. Progres-
sion at 6 M was deﬁned as the sum of
eye with progression at 3 M and 6 M
follow-up. Supplementary PRP was
given for patients with progression of
PDR at either follow-up.
Image assessment
Optic disc (OD) centred 45° fundus
images (3D OCT-2000 Spectral domain
OCT) acquired at baseline, 3 M, and
6 M were used for retinal vessel geom-
etry analyses. The vessel geometry
analyses were performed using the
veriﬁed semiautomated SIVA software
(Singapore I Vessel Assessment,
National University of Singapore, Sin-
gapore, software version 4). All images
were graded by a single-trained grader
(TLT) in accordance to the SIVA
grading protocol. The equipment and
technique are described elsewhere
(Sasongko et al. 2010; Crosby-Nwaobi
et al. 2012). In brief, the software
automatically detects the OD and
places a three-zoned grid around it.
Zone A, Zone B and Zone C located
0–2.0 disc diameters from the OD
(Fig. 1). We measured the following:
the central retinal artery and vein
calibre were estimated using the ‘Big-
6-formula’ (Knudtson et al. 2003). The
vessel tortuosity which is an index of
how curvy the retinal vessels are as
compared to a straight line of the same
vessel segment. The FD summarizes the
complexity and density of branching of
the retinal vascular tree in a single
noninteger variable. The length diam-
eter ratio (LDR) is a measure of the
calibre which is independent of refrac-
tive magniﬁcation power of the eye.
The BC indicates the change in vessel
diameter from the parent vessel to the
two daughter vessels across a bifurca-
tion. The junctional exponent deviation
(JED) is deﬁned as the extent to which
the relationship between the diameter
of the parent vessel and the daughter
vessels deviates from theoretically
deﬁned optimum.
All vessel geometric variables of
interest (calibre, tortuosity, FD, LDR,
BA, BC and JED) (Fig. 2) were mea-
sured in Zone C. The grader was
allowed to adjust the pretraced OD
location, arterioles (red) and venules
(blue) according to the grading proto-
col. Images were deﬁned as ungradable
if less than four arterioles or venules
were traced or if the cut-oﬀ region took
up more than half of a quadrant in
Zone C.
Statistical analyses
All statistical calculations were per-
formed using STATA 14.1 (StataCorp,
College Station, TX), and p-values
under 0.05 were considered statistically
signiﬁcant. We only included one eye
from patients with biocular PDR
because of the known potential corre-
lation between two eyes from the same
patient (Armstrong 2013). At baseline,
categorical data are presented as per-
centage and continuous data concern-
ing demographic data as mean with
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standard deviation (SD). Vessel geo-
metric variables are presented as med-
ian with interquartile range (IQR).
Diﬀerences between patients with
progression and nonprogression of
PDR were compared by the Wilcoxon
rank-sum test for continuous data and
Chi-squared test for categorical data.
The Wilcoxon matched-pairs signed-
rank test was used when comparing
data from baseline to follow-up on the
same patient. The nonparametric Cuz-
ick test was used to test for trends
across time-points (BL, 3 M, 6 M) in
matched data.
Results
We examined 38 eyes from 38 patients.
One patient died before 3 M follow-up,
thus 37 eyes completed the 6 M follow-
up. At baseline, the mean  SD age
and duration of diabetes were
52.8  13.7 and 22.4  12.1 years,
and 65% were male. Mean HbA1c
was 69.9 mmol/mol, and blood pres-
sure was 155/84 mmHg. At baseline,
patients in the two groups (postlaser
nonprogression and progression of
PDR) did not diﬀer according to age,
sex, duration of diabetes, HbA1c,
blood pressure, vessel geometric vari-
ables (data not shown) or total amount
of laser energy delivered to the retina
(Table 1).
Eight (22%) study eyes had progres-
sion of PDR, at 3 M. We found no
diﬀerence between the two groups by
baseline characteristics or by any of the
retinal vessel geometric variables
(Table 2). We found a statistical sig-
niﬁcant increment in FD from baseline
to 3 M follow-up (nonprogression of
PDR 1.490  0.051 versus
1.499  0.054, p = 0.04, progression
of PDR 1.487  0.077 versus
1.501  0.051, p = 0.03). Further-
more, a statistical signiﬁcant increment
in the venular BC from baseline to 3 M
was seen in patients with nonprogres-
sion of PDR (BC 1.32  0.12 versus
1.37  0.16, p 0.01).
A total of 13 (35%) study eyes
progressed in PDR during the 6 M
follow-up. We found no diﬀerences
between the two groups comparing
baseline features (Table 2). Patients
with progression of PDR deviated
more from the theoretical optimal BA
than patients with nonprogression of
PDR at 6 M (82.85°  18.55° versus
70.85°  21.56°, p = 0.01). Further-
more, we found a temporal trend of
decreased arteriolar branching angle in
patients with nonprogression of PDR
from BL via 3 M to 6 M follow-up
(p = 0.04) (data not shown). In addi-
tion, all diﬀerences seen at 6 M were
found on the arteriolar side in
patients with favourable treatment
Fig. 1. The grid from the semiautomated vessel grading software SIVA as placed on an optic disc
centred 45° fundus image. Arterioles and venules drawn as red and blue lines. Zones A, B and C
are located 0.0–0.5, 0.5–1.0 and 1.0–2.0 disc diameters from the edge of the optic disc, respectively.
All geometric variables are measured in Zone C.
Fig. 2. Deﬁnition of the retinal vessel geometric variables. Yellow lines are traced retinal vessels,
and blue lines, arrows and titles are drawn to explain the math used to deﬁne the geometric
variables. D0 = parent vessel diameter (lm), D1 = diameter of daughter vessel one (lm),
D2 = diameter of daughter vessel two (lm), h1 = angle between daughter vessel one and
imaginary progress of parent vessel if no branching had occurred (degree), h2 = angle between
daughter vessel two and imaginary progress of parent vessel if no branching had occurred
(degree), L = strait line from branching point to branching point, length diameter ratio = L/D0,
branching angle = h1+h2, branching coeﬃcient = ðD1 þD2Þ2=d20, junctional exponent deviation
ðD30 D31 D32Þ1=3
 
=D0.
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outcome. The arteriolar calibre
increased (154.3  16.8 lm versus
159.5  23.9 lm, p = 0.04), and the
tortuosity decreased (1.12  0.04 ver-
sus 1.10  0.04, p = 0.04) from base-
line to 6 M.
Discussion
In this prospective interventional study
of patients with treatment-na€ıve PDR,
we found that patients with successful
PRP had changes in retinal arterial and
venular structures during the ﬁrst
6 months after PRP. However, the
treatment outcome of PRP and
whether eyes with PDR progressed
could not be predicted by baseline
retinal vascular geometry alone. Thus,
while suﬃcient PRP leads to structural
retinal modiﬁcations not found in
patients with progressive disease, base-
line retinal geometry was not useful in
predicting disease progression.
Three months after PRP, we
observed statistical signiﬁcant changes
in the FD independent of the treatment
response. Earlier studies have found a
decreased in FD in patients with PDR
who earlier had been treated with PRP
(Grauslund et al. 2010; Pedersen et al.
2016), and a 16-year prospective study
by Broe et al. found that for every .01
decreased in FD the risk of PDR
increased with 22% (Broe et al.
2014b). A potential explanation could
be that progressive ischaemia results in
an auto-regulatory-mediated lower
complexity and density of branching of
the retinal vascular tree. In the short-
term, PRP may reverse this process, but
due to the underlying progressive nature
of the disease, this temporary eﬀect is
lost again a few months later.
The BC explains the relationship
between the calibres of the parent
vessel compared to the daughter vessels
at a bifurcation. The venular BC
increased in patients with favourable
treatment outcome from baseline to
3 M. It is diﬃcult to determine if the
changes in the BC is due the parent
vessel decreasing or daughter vessels
increasing in calibre. However, because
the venular calibre did not change from
baseline to 3 M, it could be argued that
the daughter vessels increased in diam-
eter, to obtain a more optimal rela-
tionship between parent and daughter
vessel calibre in patients with favour-
able treatment outcome. Branching
coeﬃcient (BC) has not been studied
to the same extent as many of the other
vascular variables, and therefore, the
association to PDR is unclear.
Six months after PRP, only eyes that
stabilized in PDR developed changes in
the retinal arteriolar structure. In a
cross-sectional study from WESDR,
Klein et al. found statistical signiﬁcant
smaller retinal arteriolar and venular
vessel calibre in patients with PDR
previously treated with PRP compared
to patients without such treatment
(Klein et al. 2006). The same results
were found in a prospective study by
Wilson et al. (1988). In a prospective
study by Broe et al. it was shown that
a decrease in arteriolar vessel calibre
was signiﬁcantly associated with the
16-year incidence of PDR (Broe et al.
2014a). We found an increase in the
arteriolar vessel calibre that could rep-
resent a positive response to the PRP
treatment with a lower hypoxic load on
the retina and a subsequent auto-
regulatory arteriolar dilation. We did
not ﬁnd any association between
changes in the venular vessel calibre
from baseline to 6 M. Several studies
have reported on retinal vasoconstric-
tive eﬀect of PRP (Gottfredsdottir
et al. 1993; Grunwald et al. 1993).
Gottfredsdottir et al. (1993) found an
overall retinal vessel constriction in
patients with diabetic macular oedema
treated with macular laser photocoag-
ulation. Grunwald et al. (1993)
reported on a retinal vasoconstrictive
eﬀect of PRP that may be due to a
metabolic response, although this was
not stratiﬁed to the treatment outcome
and was performed on a limited cohort
of patients with PDR.
In patients with favourable treat-
ment outcome, the arteriolar vessel
tortuosity decreased from baseline to
6 M, thus making the arterioles less
twisted. One explanation could be that
the hypoxic load increases with
increased levels of DR. When the
patient develops PDR, the vascular
tree alters appearance and the overall
tortuosity increases. After receiving
suﬃcient PRP treatment, the hypoxic
drive is diminished and the retinal
vessels changes to a more ‘normal’
appearance (e.g. less tortuous), thus
agreeing with the sparse literature on
the area (Crosby-Nwaobi et al. 2012).
Although the changes seen in the tor-
tuosity were on the arteriolar side, the
same mechanism, and to some extent,
the same explanation may apply on the
venular side, thus we found patients
with nonprogression of PDR to be
closer to the theoretical optimum BA
when compared to patients with pro-
gression of PDR at 6 M. Additionally,
patients with nonprogression of PDR
showed a trend towards an overall
decrease in BA across all time-points,
whereas patients with progression of
PDR were somewhat unchanged.
Although patients with nonprogression
of PDR decreased in BA, the group
still showed a less theoretical optimal
BA at 6 M compared to BL. This
change could be seen as a persistent
ability to alter the vascular appearance,
in patients with favourable treatment
response.
The strengths of this study were the
prospective design, and the use of a
semiautomated, validated computer
software for analysing retinal vascular
parameters. Patients only participated
with one eye, thus strengthen the statis-
tical ﬁnds in this study. Limitations
include a limited sample size, and the
Table 1. Demographic baseline characteristics for patients with subsequent nonprogression and
progression of proliferative diabetic retinopathy after panretinal photocoagulation.
Demographic data
Nonprogression of PDR Progression of PDR
p valueMean (SD) Mean (SD)
n 24 14
Age, years 53.8 (13.9) 49.1 (14.9) 0.39
Sex, Male % 71% 50% 0.19
Duration of diabetes, years 22.7 (12.7) 21.1 (11.3) 0.70
HbA1c, mmol/mol 71 (20) 69 (18) 0.79
Systolic blood pressure, mmHg 158 (24) 146 (23) 0.23
Diastolic blood pressure, mmHg 86 (15) 82 (14) 0.71
Laser energy, Joule 12.26 (3.70) 12.29 (3.33) 0.98
Baseline characteristics in accordance to the number of patients with progression and
nonprogression at follow-up month six. All values are represented as mean  standard deviation
(SD).
PDR = Proliferative diabetic retinopathy.
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lack of an untreated observation group,
which was not possible for ethical rea-
sons. Furthermore, the retinal vessel
geometric variables may to some extent
be correlated with the degree of refrac-
tive deviations such as high myopia,
which was not possible due to lack of
refractive data, although this correlation
may be less important when evaluating
vascular geometric changes over time.
In conclusion, our prospective
cohort study showed that the overall
baseline retinal vessel geometry could
not predict the stability or activity of
PDR after PRP treatment, there were
measurable changes in the retinal vessel
geometry over 6 months in eyes with
favourable PRP treatment outcome,
reﬂecting structural vessel changes in
response to possibly changes in meta-
bolic demand in the retina. Hence,
structural retinal arteriolar and venular
changes may serve as an individual
marker of laser eﬃcacy in PDR.
Table 2. Changes in retinal vascular geometrical variables in patients with nonprogression and progression of proliferative diabetic retinopathy three
and six months after panretinal photocoagulation.
Retinal vascular morphology
3 months 6 months
n
BL 3 M
p value n
BL 6 M
p valueMedian (IQR) Median (IQR) Median (IQR) Median (IQR)
Calibre (lm)
Arterial Nonprogression 29 155.1 (20.3) 153.4 (17.9) 0.75 24 154.3 (16.8) 159.5 (23.9) 0.04*
Progression 8 161.3 (32.1) 161.6 (27.7) 0.77 13 163.9 (24.4) 159.0 (19.9) 0.91
p value 0.53 0.76 0.40 0.75
Venous Nonprogression 29 240.6 (29.0) 237.3 (23.6) 0.99 24 238.8 (32.9) 235.3 (40.4) 0.21
Progression 8 234.2 (14.9) 234.1 (14.9) 0.48 13 234.2 (15.9) 234.4 (21.9) 0.46
p value 0.60 0.60 0.82 0.80
Length diameter ratio
Arterial Nonprogression 26 16.13 (11.58) 18.32 (7.97) 0.13 22 16.13 (11.58) 13.18 (11.72) 0.38
Progression 7 18.25 (11.93) 16.90 (10.19) 0.73 11 17.24 (11.93) 18.28 (12.23) 0.85
p value 0.79 0.79 0.93 0.33
Venous Nonprogression 26 12.57 (8.53) 13.72 (6.47) 0.08 22 12.57 (7.33) 14.50 (7.67) 0.24
Progression 7 15.74 (5.47) 16.47 (6.32) 0.73 11 15.24 (9.04) 12.87 (5.34) 1.00
p value 0.09 0.48 0.18 0.73
Fractal Dimension
Nonprogression 29 1.490 (0.051) 1.499 (0.054) 0.04* 24 1.490 (0.066) 1.481 (0.108) 0.54
Progression 8 1.487 (0.077) 1.501 (0.051) 0.03* 13 1.490 (0.044) 1.508 (0.035) 0.38
p value 0.78 0.59 0.86 0.37
Tortuosity
Arterial Nonprogression 29 1.12 (0.04) 1.12 (0.04) 0.89 24 1.12 (0.04) 1.10 (0.04) 0.04*
Progression 8 1.11 (0.04) 1.11 (0.06) 0.67 13 1.12 (0.04) 1.12 (0.03) 0.29
p value 0.98 0.88 0.58 0.16
Venous Nonprogression 29 1.10 (0.02) 1.10 (0.02) 0.81 24 1.10 (0.02) 1.10 (0.03) 0.15
Progression 8 1.11 (0.03) 1.10 (0.02) 0.32 13 1.10 (0.02) 1.11 (0.2) 0.38
p value 0.57 0.47 0.92 0.50
Branching angle (degree)
Arterial Nonprogression 29 79.16 (20.21) 78.38 (13.18) 0.53 24 76.09 (21.40) 70.85 (21.56) 0.15
Progression 8 80.18 (18.19) 84.88 (7.95) 0.88 13 81.15 (14.49) 82.85 (18.55) 0.97
p value 0.39 0.13 0.26 0.01*
Venous Nonprogression 29 80.64 (8.87) 80.12 (8.93) 0.59 24 80.66 (10.30) 80.13 (16.93) 0.49
Progression 8 81.41 (5.65) 81.20 (8.41) 0.77 13 80.82 (5.52) 81.46 (11.42) 0.64
p value 0.68 0.88 0.75 0.58
Branching coeﬃcient
Arterial Nonprogression 29 1.47 (0.14) 1.52 (0.32) 0.65 24 1.50 (0.20) 1.50 (0.28) 0.24
Progression 8 1.48 (0.11) 1.45 (0.38) 1.00 13 1.45 (0.10) 1.47 (0.15) 0.70
p value 0.91 0.79 0.61 0.44
Venous Nonprogression 29 1.32 (0.12) 1.37 (0.16) 0.01* 24 1.32 (0.13) 1.35 (0.27) 0.58
Progression 8 1.32 (0.11) 1.40 (0.22) 0.16 13 1.32 (0.11) 1.34 (0.16) 1.00
p value 0.85 0.71 0.71 0.79
Junctional exponent deviation
Arterial Nonprogression 29 0.50 (0.30) 0.58 (0.49) 0.70 24 0.49 (0.40) 0.46 (0.37) 0.20
Progression 8 0.59 (0.29) 0.46 (0.56) 0.77 13 0.58 (0.23) 0.48 (0.35) 0.24
p value 0.53 0.81 0.42 0.88
Venous Nonprogression 29 0.26 (0.24) 0.36 (0.31) 0.06 24 0.26 (0.14) 0.31 (0.52) 0.84
Progression 8 0.30 (0.28) 0.47 (0.27) 0.26 13 0.35 (0.30) 0.26 (0.30) 0.75
p value 0.94 0.67 0.58 0.94
All values are represented as median + interquartile range (IQR). Diﬀerences between patients with nonprogression and progression of proliferative
diabetic retinopathy (PDR) (unpaired data) are given vertically, and changes from baseline (BL) to follow-up 3 months (3 M) or 6 months (6 M)
(paired data) are represented horizontally.
* Statistically signiﬁcant.
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